LEARNING OBJECTIVES
- Define and diagnosis sarcopenia and frailty in patients with chronic liver disease
- Describe the consequences of sarcopenia and frailty in patients with chronic liver disease
- Evaluate treatment options for sarcopenia and frailty in patients with chronic liver disease
FACULTY AND TOPICS
Sarcopenia – Causes and Outcomes in Patients with Chronic Liver Disease
Matthias Pirlich, MD, PhD, Physician, Departments of Endocrinology, Gastroenterology, and Clinical Nutrition, Imperial Oak Outpatient Clinic, Berlin, Germany
Frailty – Causes and Outcomes in Patients with Chronic Liver Disease
Andres Duarte-Rojo, MD, PhD, Associate Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA
The Cost of Sarcopenia and Frailty: Implementing Therapies for Patients with Chronic Liver Disease
Jeanette Hasse, PhD, RD, LD, FADA, CNSC, Transplant Nutrition Manager, Baylor Simmons Transplant Institute, Baylor University Medical Center; Editor-in-Chief, Nutrition in Clinical Practice, Dallas, TX
MODERATOR
Jeanette Hasse, PhD, RD, LD, FADA, CNSC
CE Credit: 1.5 hours
Level: Intermediate
UAN: JA0002345-0000-21-039-L01-P
This session has been approved for BCNSP recertification credit of 1.5 hours.